stoxline Quote Chart Rank Option Currency Glossary
  
Arcadia Biosciences, Inc. (RKDA)
2.66  -0.15 (-5.34%)    07-26 16:00
Open: 2.8001
High: 3.0388
Volume: 21,109
  
Pre. Close: 2.81
Low: 2.5703
Market Cap: 4(M)
Technical analysis
2024-07-26 4:46:53 PM
Short term     
Mid term     
Targets 6-month :  3.54 1-year :  3.87
Resists First :  3.03 Second :  3.31
Pivot price 3.02
Supports First :  2.57 Second :  2.13
MAs MA(5) :  2.9 MA(20) :  3.03
MA(100) :  2.6 MA(250) :  2.97
MACD MACD :  -0.1 Signal :  0
%K %D K(14,3) :  4.4 D(3) :  11.6
RSI RSI(14): 35.9
52-week High :  4.86 Low :  1.85
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ RKDA ] has closed below the lower bollinger band by 16.9%. If price is in a downtrend band; this downward trend might continue. However a short term pullback inside the band is likely. Bollinger Bands are 10.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.04 - 3.06 3.06 - 3.08
Low: 2.52 - 2.55 2.55 - 2.57
Close: 2.62 - 2.66 2.66 - 2.69
Company Description

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.

Headline News

Fri, 26 Jul 2024
Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.com - Defense World

Thu, 18 Jul 2024
Arcadia Biosciences (NASDAQ:RKDA) Shares Pass Above 50 Day Moving Average of $2.98 - Defense World

Wed, 17 Jul 2024
Arcadia Biosciences (RKDA) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance

Tue, 09 Jul 2024
Arcadia Biosciences (RKDA) Announces Leadership Transition - StockTitan

Tue, 09 Jul 2024
Arcadia Biosciences (RKDA) Announces Leadership Transition - Business Wire

Mon, 08 Jul 2024
On July 2, Arcadia Biosciences & Stanley Jacot, Jr. Entered Into Separation And Release Agreement Pursuant To Which Jacot Resigned As Co's CEO; Appointed Thomas J. Schaefer To Position Of President And CEO, Effective As Of July 5, 2024 - Quantisnow

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Basic Materials
Industry:
Agricultural Inputs
Shares Out 1 (M)
Shares Float 1 (M)
Held by Insiders 2.6 (%)
Held by Institutions 2.9 (%)
Shares Short 57 (K)
Shares Short P.Month 72 (K)
Stock Financials
EPS -1.77
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.78
Profit Margin -131.2 %
Operating Margin -241.2 %
Return on Assets (ttm) -33.8 %
Return on Equity (ttm) -47 %
Qtrly Rev. Growth 1.8 %
Gross Profit (p.s.) 0
Sales Per Share 3.93
EBITDA (p.s.) -9.04
Qtrly Earnings Growth 0 %
Operating Cash Flow -15 (M)
Levered Free Cash Flow -6 (M)
Stock Valuations
PE Ratio -1.51
PEG Ratio -0.2
Price to Book value 0.34
Price to Sales 0.67
Price to Cash Flow -0.25
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android